Top Markets
Coin of the day
Chinook Therapeutics, Inc. Chinook Therapeutics, Inc.

Chinook Therapeutics, Inc.

KDNY
शेयरों में रैंक #7142
Chinook Therapeutics, Inc., a biotechnology enterprise in the clinical... Chinook Therapeutics, Inc., a biotechnology enterprise in the clinical development phase, is dedicated to the identification, progression, and market introduction of precise medical treatments for kidney-related conditions. The company's primary therapeutic candidate, atrasentan, is an endothelin receptor antagonist currently in Phase III clinical trials. This drug aims to treat IgA nephropathy and various other glomerular diseases characterized by proteinuria. Beyond its lead program, Chinook's investigational pipeline includes BION-1301, an anti-APRIL monoclonal antibody, which is presently being evaluated in a Phase I/II study for IgA nephropathy. Another promising candidate is CHK-336, an oral small molecule designed to inhibit LDHA, intended for patients with primary hyperoxaluria. The firm also maintains active research initiatives exploring solutions for other uncommon and severe chronic kidney ailments. Chinook Therapeutics, Inc. is based in Seattle, Washington.
शेयर मूल्य
$40.39
अंतिम समन्वयन: 2023-08-18
मार्केट कैप
$1.70B
बदलाव (1 दिन)
0.00%
बदलाव (1 वर्ष)
0.00%
देश
US
व्यापार Chinook Therapeutics, Inc. (KDNY)

श्रेणी

Chinook Therapeutics, Inc. (KDNY) के लिए डिविडेंड यील्ड इतिहास
Chinook Therapeutics, Inc. (स्टॉक सिंबल: KDNY) की डिविडेंड यील्ड (TTM) 2026 को: 0
पिछले 5 वर्षों की औसत डिविडेंड यील्ड: 0.00%
Chinook Therapeutics, Inc. (KDNY) के लिए 2026 से 2026 तक की डिविडेंड यील्ड का इतिहास
प्रत्येक वर्ष के अंत में डिविडेंड यील्ड (TTM)
वर्ष डिविडेंड यील्ड परिवर्तन
प्रदान की गई तारीखों के लिए पर्याप्त डेटा नहीं।
समान कंपनियों या प्रतिस्पर्धियों के लिए डिविडेंड यील्ड (TTM)
कंपनी डिविडेंड यील्ड देश
0.00%
US
0.00%
NL
3.12%
AU
0.00%
US
0.00%
CH